| Melissa D Meredith, CNM | |
|
4745 Ogletown Stanton Rd Ste 106, Newark, DE 19713-1339 | |
| (302) 454-9800 | |
| (302) 454-6446 |
| Full Name | Melissa D Meredith |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 20 Years |
| Location | 4745 Ogletown Stanton Rd Ste 106, Newark, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427090745 | NPI | - | NPPES |
| 1427090745 | Medicaid | DE | |
| LT35 / 606879-02 | Other | MD | BC / BS OF MD |
| S186 / 0072 | Other | MD | BLUECHOICE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | LK0000136 (Delaware) | Primary |
| 367A00000X | Advanced Practice Midwife | AC000100 (Maryland) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tidalhealth Physician Network, Inc. | 7315901253 | 75 |
News Archive
A program to give naloxone overdose-antidote kits and training to front-line officers. Funding for pill disposal boxes in pharmacies, clinics and police stations across North Carolina. A radio campaign in Connecticut warning of the dangers of opioid abuse. A new medicine to treat opioid-induced constipation.
WisTa Laboratories Ltd, a wholly owned subsidiary of TauRx Pharmaceuticals, announced today that they have entered a collaborative R&D agreement with Bayer Schering Pharma AG, Germany, which could redefine the way Alzheimer's disease (AD) and related disorders are currently being diagnosed and treated.
Infosys, a global leader in technology, consulting and outsourcing solutions, has been recognized as a winner in the 2014 Simulating Reality contest. The contest is organized by MSC Software, a worldwide leader of multidisciplinary simulation solutions.
When parents treat their children differently, siblings and parents often have very different ideas about what's happening and why, says a University of Illinois study. And there can be as many points of view as there are family members.
Ikaria, Inc. announced today that its INOMAX® DS drug-delivery systems in the United States are being voluntarily recalled due to the potential failure of a pressure switch which may have an impact on the administration of INOMAX® (nitric oxide) for inhalation to patients. This potential failure was identified by Ikaria as part of its ongoing quality monitoring and review processes. This class I recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA). All INOMAX DS systems in Canada also are being voluntarily recalled.
› Verified 2 days ago
| Entity Name | Tidalhealth Physician Network, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467534636 PECOS PAC ID: 7315901253 Enrollment ID: O20041119000090 |
News Archive
A program to give naloxone overdose-antidote kits and training to front-line officers. Funding for pill disposal boxes in pharmacies, clinics and police stations across North Carolina. A radio campaign in Connecticut warning of the dangers of opioid abuse. A new medicine to treat opioid-induced constipation.
WisTa Laboratories Ltd, a wholly owned subsidiary of TauRx Pharmaceuticals, announced today that they have entered a collaborative R&D agreement with Bayer Schering Pharma AG, Germany, which could redefine the way Alzheimer's disease (AD) and related disorders are currently being diagnosed and treated.
Infosys, a global leader in technology, consulting and outsourcing solutions, has been recognized as a winner in the 2014 Simulating Reality contest. The contest is organized by MSC Software, a worldwide leader of multidisciplinary simulation solutions.
When parents treat their children differently, siblings and parents often have very different ideas about what's happening and why, says a University of Illinois study. And there can be as many points of view as there are family members.
Ikaria, Inc. announced today that its INOMAX® DS drug-delivery systems in the United States are being voluntarily recalled due to the potential failure of a pressure switch which may have an impact on the administration of INOMAX® (nitric oxide) for inhalation to patients. This potential failure was identified by Ikaria as part of its ongoing quality monitoring and review processes. This class I recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA). All INOMAX DS systems in Canada also are being voluntarily recalled.
› Verified 2 days ago
| Entity Name | Lifeline Medical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821041617 PECOS PAC ID: 1456332170 Enrollment ID: O20200715000109 |
News Archive
A program to give naloxone overdose-antidote kits and training to front-line officers. Funding for pill disposal boxes in pharmacies, clinics and police stations across North Carolina. A radio campaign in Connecticut warning of the dangers of opioid abuse. A new medicine to treat opioid-induced constipation.
WisTa Laboratories Ltd, a wholly owned subsidiary of TauRx Pharmaceuticals, announced today that they have entered a collaborative R&D agreement with Bayer Schering Pharma AG, Germany, which could redefine the way Alzheimer's disease (AD) and related disorders are currently being diagnosed and treated.
Infosys, a global leader in technology, consulting and outsourcing solutions, has been recognized as a winner in the 2014 Simulating Reality contest. The contest is organized by MSC Software, a worldwide leader of multidisciplinary simulation solutions.
When parents treat their children differently, siblings and parents often have very different ideas about what's happening and why, says a University of Illinois study. And there can be as many points of view as there are family members.
Ikaria, Inc. announced today that its INOMAX® DS drug-delivery systems in the United States are being voluntarily recalled due to the potential failure of a pressure switch which may have an impact on the administration of INOMAX® (nitric oxide) for inhalation to patients. This potential failure was identified by Ikaria as part of its ongoing quality monitoring and review processes. This class I recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA). All INOMAX DS systems in Canada also are being voluntarily recalled.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa D Meredith, CNM 801 Middleford Rd, Seaford, DE 19973-3636 Ph: (302) 629-6611 | Melissa D Meredith, CNM 4745 Ogletown Stanton Rd Ste 106, Newark, DE 19713-1339 Ph: (302) 454-9800 |
News Archive
A program to give naloxone overdose-antidote kits and training to front-line officers. Funding for pill disposal boxes in pharmacies, clinics and police stations across North Carolina. A radio campaign in Connecticut warning of the dangers of opioid abuse. A new medicine to treat opioid-induced constipation.
WisTa Laboratories Ltd, a wholly owned subsidiary of TauRx Pharmaceuticals, announced today that they have entered a collaborative R&D agreement with Bayer Schering Pharma AG, Germany, which could redefine the way Alzheimer's disease (AD) and related disorders are currently being diagnosed and treated.
Infosys, a global leader in technology, consulting and outsourcing solutions, has been recognized as a winner in the 2014 Simulating Reality contest. The contest is organized by MSC Software, a worldwide leader of multidisciplinary simulation solutions.
When parents treat their children differently, siblings and parents often have very different ideas about what's happening and why, says a University of Illinois study. And there can be as many points of view as there are family members.
Ikaria, Inc. announced today that its INOMAX® DS drug-delivery systems in the United States are being voluntarily recalled due to the potential failure of a pressure switch which may have an impact on the administration of INOMAX® (nitric oxide) for inhalation to patients. This potential failure was identified by Ikaria as part of its ongoing quality monitoring and review processes. This class I recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA). All INOMAX DS systems in Canada also are being voluntarily recalled.
› Verified 2 days ago
Lindsay Dormer Robinson, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2600 Glasgow Ave Ste 207, Newark, DE 19702 Phone: 028-321-1243 | |
Angela M Madariaga, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4745 Ogletown Stanton Rd Ste 105, Newark, DE 19713 Phone: 302-368-3257 | |
Alexandrea Caroline Russell, CNM, WHNP-BC Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4745 Ogletown-stanton Rd, Map 1, Suite 200, Newark, DE 19713 Phone: 302-454-9800 |